SynthesisSocial psychiatry and psychiatric epidemiology2022
Assessing cognition in people with severe mental disorders in low- and middle-income countries: a systematic review of assessment measures.
Synthesis in Social psychiatry and psychiatric epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Exploring the Relationship between Cognitive Performance, Performance-Based Functioning, and Everyday Functioning in People with Schizophrenia: a Systematic Literature Review.Schizophrenia bulletin · 2026Pooled it
- Effectiveness of Non-Pharmacological Interventions for Reducing Self-Stigma in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis.Healthcare (Basel, Switzerland) · 2026Review
- The association between mental health and cognitive ability: Evidence from the Understanding Society survey.PloS one · 2025Article
- Development and Evaluation of a Cognitive Battery for People With Schizophrenia in Ethiopia.Schizophrenia bulletin · 2024Article
- The Ethiopian Cognitive Assessment battery in Schizophrenia (ECAS): a validation study.Schizophrenia (Heidelberg, Germany) · 2024Article
- Associations between breakfast skipping and outcomes in neuropsychiatric disorders, cognitive performance, and frailty: a Mendelian randomization study.BMC psychiatry · 2024Article
- Physical activity and sedentary behavior levels among individuals with mental illness: A cross-sectional study from 23 countries.PloS one · 2024Article
- Advancing public health: enabling culture-fair and education-independent automated cognitive assessment in low- and middle-income countries.Frontiers in public health · 2024Article
- The relationship between cognitive functioning, age and employment in people with severe mental illnesses in an urban area in India: A longitudinal study.Schizophrenia research. Cognition · 2022Article
- The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.Health and quality of life outcomes · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCognitive difficulties are common in people with severe mental disorders (SMDs) and various measures of cognition are of proven validity. However, there is a lack of systematic evidence regarding the psychometric properties of these measures in low- and middle-income countries (LMICs).
objectiveTo systematically review the psychometric properties of cognitive measures validated in people with SMDs in LMICs.
methodsWe conducted a systematic review of the literature by searching from four electronic databases. Two authors independently screened studies for their eligibility. Measurement properties of measures in all included studies were extracted. All eligible measures were assessed against criteria set for clinical and research recommendations. Results are summarized narratively and measures were grouped by measurement type and population.
resultsWe identified 23 unique measures from 28 studies. None of these was from low-income settings. Seventeen of the measures were performance-based. The majority (n = 16/23) of the measures were validated in people with schizophrenia. The most commonly reported measurement properties were: known group, convergent, and divergent validity (n = 25/28). For most psychometric property, studies of methodological qualities were found to be doubtful. Among measures evaluated in people with schizophrenia, Brief Assessment of Cognition in Schizophrenia, Cognitive Assessment Interview, MATRICS Consensus Cognitive Battery, and CogState Schizophrenia Battery were with the highest scores for clinical and research recommendation.
conclusionsStudies included in our review provide only limited quality evidence and future studies should consider adapting and validating measures using stronger designs and methods. Nonetheless, validated assessments of cognition could help in the management and allocating therapy in people with SMDs in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.